​Israeli researchers have started pre-clinical studies to examine the impact of medical cannabis in the treatment of endometriosis, a medical problem that affects... Israeli researchers probe how cannabis can treat endometriosis

Disease that affects 10% of women of childbearing age can cause severe pain and bleeding

Israeli researchers have started pre-clinical studies to examine the impact of medical cannabis in the treatment of endometriosis, a medical problem that affects one in 10 women of childbearing age.

The research is led by Gynica, which is licensed by the Health Ministry to develop cannabis-based products for women, in cooperation with Lumir Lab, a cannabis research facility in the Biotechnology Park, Hadassah Ein Karem, Jerusalem.

Endometriosis affects some 176 million women worldwide. In affected women, uterine lining grows outside the uterus, in the fallopian tubes, ovaries and other areas of the abdominal cavity and in the pelvis. These women suffer from severe pain before and during menstruation, bleeding and pain during and after intercourse, dyspepsia and frequent or painful urination.

Anecdotal evidence has shown that women who smoke cannabis find relief from their pain, said Dr. Sari Sagiv, VP of research and development at Gynica. The researchers set out to find out what compounds or combination of compounds of cannabis can potentially address the problem.

MJ Shareholders avatar

MJ Shareholders

MJShareholders.com is the largest dedicated financial network and leading corporate communications firm serving the legal cannabis industry. Our network aims to connect public marijuana companies with these focused cannabis audiences across the US and Canada that are critical for growth: Short and long term cannabis investors Active funding sources Mainstream media Business leaders Cannabis consumers




( ) ( ) ( ) ( ) ( ) ( ) ( ) ( )